Safety and efficacy of depatuxizumab mafodotin monotherapy or in combination with temozolomide in patients with/without EGFR-amplified recurrent glioblastoma: a systematic review
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Medicine and Surgery"
DOI: 10.1097/ms9.0000000000003869
Abstract: This study aimed to assess the safety and efficacy of depatuxizumab mafodotin as a monotherapy or in combination with temozolomide in patients with recurrent epidermal growth factor receptor (EGFR)-amplified glioblastoma multiforme, focusing on overall survival… read more here.
Keywords: mafodotin; combination; efficacy depatuxizumab; depatuxizumab mafodotin ... See more keywords